GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » No.25 Central Pharmaceutical JSC (HSTC:UPH) » Definitions » Land And Improvements

No.25 Central Pharmaceutical JSC (HSTC:UPH) Land And Improvements : ₫0.00 Mil (As of . 20)


View and export this data going back to 2016. Start your Free Trial

What is No.25 Central Pharmaceutical JSC Land And Improvements?

No.25 Central Pharmaceutical JSC's land and improvements for the quarter that ended in . 20 was ₫0.00 Mil.


No.25 Central Pharmaceutical JSC Land And Improvements Historical Data

The historical data trend for No.25 Central Pharmaceutical JSC's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

No.25 Central Pharmaceutical JSC Land And Improvements Chart

No.25 Central Pharmaceutical JSC Annual Data
Trend
Land And Improvements

No.25 Central Pharmaceutical JSC Semi-Annual Data
Land And Improvements

No.25 Central Pharmaceutical JSC Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.


No.25 Central Pharmaceutical JSC Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
448B Nguyen Tat Thanh, Ward 18, District 4, Ho Chi Minh, VNM
No.25 Central Pharmaceutical JSC is engaged in the manufacturing and trading of pharmaceutical products and cosmetics. Its products comprise Rheumatin, Tribelus, Atorvastatin, and Cezirate among others.

No.25 Central Pharmaceutical JSC Headlines

No Headlines